Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Rohto Pharmaceutical Co ( (JP:4527) ) has provided an announcement.
Rohto Pharmaceutical Co., Ltd. announced significant leadership changes, including the appointment of Hidetoshi Segi as the new President and Chief Operating Officer, effective after the upcoming shareholders’ meeting. These changes are expected to strengthen the company’s management foundation and drive future growth, with Segi’s leadership focusing on both existing and new business development.
More about Rohto Pharmaceutical Co
Rohto Pharmaceutical Co., Ltd. is a company operating in the pharmaceutical industry, primarily focused on the development, production, and marketing of healthcare products. The company is known for its innovative approach in product planning and international business, aiming to achieve sustainable growth and innovation.
Average Trading Volume: 1,369,536
Technical Sentiment Signal: Sell
Current Market Cap: Yen561.5B
See more data about 4527 stock on TipRanks’ Stock Analysis page.